Skip to main content

RheumNow Live (RNL), 2025

Filter
Close
Content type:
Bimekizumab efficacy and safety in patients with psoriatic arthritis who had skin and nail psoriasis at baseline: Up to 2-year results from two phase 3 studies
Thaci Diamant, Akihiko Asahina, Wolf-Henning Boehncke, et al.
Poster
Bimekizumab efficacy and safety in patients with psoriatic arthritis who had skin and nail psoriasis at baseline: Up to 2-year results from two phase 3 studies
Thaci Diamant, Akihiko Asahina, Wolf-Henning Boehncke, et al.
Poster
Bimekizumab-Treated Patients with Active Psoriatic Arthritis Showed Sustained Improvements in Pain and Fatigue: Up to 2-Year Results from Two Phase 3 Studies
Mease J. Philip, Tillett William, Maarten de Wit, et al.
Poster